Marksans Pharma LimitedNSE: MARKSANS

Press Release Aug 12 2025

· Issued by Marksans Pharma Limited

Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Q1FY26 Financial Results Marksans Pharma ₹620 Cr Revenue in Q1 FY26, up 5% YoY; Strong Cash Position of ₹711 Cr Supports Growth Initiatives".

View Attachment

6ix hasn’t read this filing yet.

Marksans Pharma Limited on 6ix

In the deck

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases